Healthcare provider profile · identity verified

William Clarence Brink, MD

Internal Medicine · WINCHESTER, VA · NPI 1619933447

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	924	243
Amlodipine Besylate	Amlodipine Besylate	825	219
Levothyroxine Sodium	Levothyroxine Sodium	658	149
Losartan Potassium	Losartan Potassium	489	129
Metoprolol Succinate	Metoprolol Succinate	470	136
Omeprazole	Omeprazole	463	135
Hydrochlorothiazide	Hydrochlorothiazide	453	130
Rosuvastatin Calcium	Rosuvastatin Calcium	451	121
Simvastatin	Simvastatin	440	111
Eliquis	Apixaban	382	84
Lisinopril	Lisinopril	343	88
Tamsulosin Hcl	Tamsulosin Hcl	294	83
Gabapentin	Gabapentin	222	61
Potassium Chloride	Potassium Chloride	218	81
Metformin Hcl	Metformin Hcl	208	63
Carvedilol	Carvedilol	207	54
Valsartan	Valsartan	206	61
Furosemide	Furosemide	185	55
Allopurinol	Allopurinol	183	45
Albuterol Sulfate Hfa	Albuterol Sulfate	175	64
Escitalopram Oxalate	Escitalopram Oxalate	173	54
Glimepiride	Glimepiride	171	44
Metoprolol Tartrate	Metoprolol Tartrate	167	50
Meloxicam	Meloxicam	160	47
Duloxetine Hcl	Duloxetine Hcl	155	34
Pravastatin Sodium	Pravastatin Sodium	142	35
Pantoprazole Sodium	Pantoprazole Sodium	139	39
Hydralazine Hcl	Hydralazine Hcl	131	32
Metformin Hcl Er	Metformin Hcl	124	36
Finasteride	Finasteride	121	31
Irbesartan	Irbesartan	119	32
Alendronate Sodium	Alendronate Sodium	117	37
Spironolactone	Spironolactone	113	36
Prednisone	Prednisone	107	62
Januvia	Sitagliptin Phosphate	100	24
Celecoxib	Celecoxib	97	27
Ezetimibe	Ezetimibe	90	25
Telmisartan	Telmisartan	87	21
Citalopram Hbr	Citalopram Hydrobromide	86	25
Montelukast Sodium	Montelukast Sodium	86	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	85	21
Fluticasone Propionate	Fluticasone Propionate	82	29
Jardiance	Empagliflozin	80	21
Warfarin Sodium	Warfarin Sodium	80	18
Famotidine	Famotidine	79	28
Cephalexin	Cephalexin	76	53
Synthroid	Levothyroxine Sodium	73	17
Ozempic	Semaglutide	72	11
Clopidogrel	Clopidogrel Bisulfate	71	22
Doxazosin Mesylate	Doxazosin Mesylate	69	24
Breo Ellipta	Fluticasone/Vilanterol	67	14
Sertraline Hcl	Sertraline Hcl	62	17
Triamcinolone Acetonide	Triamcinolone Acetonide	61	25
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	58	15
Cefuroxime	Cefuroxime Axetil	57	50
Olmesartan Medoxomil	Olmesartan Medoxomil	57	14
Carbidopa-Levodopa	Carbidopa/Levodopa	54	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	12
Xarelto	Rivaroxaban	53	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	suppressed
Clonazepam	Clonazepam	50	suppressed
Clonidine Hcl	Clonidine Hcl	49	13
Paroxetine Hcl	Paroxetine Hcl	47	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	45	38
Trazodone Hcl	Trazodone Hcl	44	13
Esomeprazole Magnesium	Esomeprazole Magnesium	41	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Atenolol	Atenolol	36	suppressed
Lorazepam	Lorazepam	36	13
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	36	suppressed
Benazepril Hcl	Benazepril Hcl	35	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	35	suppressed
Amoxicillin	Amoxicillin	34	28
Mirtazapine	Mirtazapine	34	12
Ondansetron Hcl	Ondansetron Hcl	34	16
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	11
Nortriptyline Hcl	Nortriptyline Hcl	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Invokana	Canagliflozin	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Rybelsus	Semaglutide	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	13
Klor-Con M20	Potassium Chloride	26	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Spiriva Respimat	Tiotropium Bromide	25	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	25	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Ramipril	Ramipril	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Glipizide Er	Glipizide	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Naproxen	Naproxen	18	suppressed
Nitroglycerin	Nitroglycerin	18	16
Azithromycin	Azithromycin	17	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	15	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Felodipine Er	Felodipine	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Nystatin	Nystatin	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Digoxin	Digoxin	14	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	14
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Livalo	Pitavastatin Calcium	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	14	suppressed
Topiramate	Topiramate	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Cefdinir	Cefdinir	13	13
Creon	Lipase/Protease/Amylase	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Multaq	Dronedarone Hcl	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Tiadylt Er	Diltiazem Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error